March 2020
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
This conference focuses on next steps for tackling antimicrobial resistance (AMR) in the UK - and the global response to AMR.
It will be an opportunity to assess priorities for improving infection prevention and control as stakeholders in health care and research begin implementation of Public Health England’s Infectious Disease Strategy 2020-2025.
Areas for discussion include:
- Supporting the infection prevention workforce;
- Developing innovative diagnostic technologies;
- Reducing the transmission of resistant bacteria; and
- The Strategy’s goal to make the UK a world leader in tackling AMR.
Further sessions will consider the progress of research into AMR, with discussion on funding, impact and supporting innovation to address AMR in humans, animals, and the environment.
The agenda includes keynote addresses from:
- Professor Dame Sally Davies, UK Special Envoy on AMR for UK Government and lately Chief Medical Officer for England;
- Professor Brian Ferguson, Chief Economist, Public Health England;
- Dr Julie Robotham, Lead, Modelling and Economics, HCAI and AMR, Public Health England; and
- Dr Gregory Amos, Head of Microbiome Section, Division of Bacteriology, National Institute for Biological Standards and Control, MHRA
There will be further contributions from: Dr Jessica Boname, Medical Research Council; Arlene Brailey, Antibiotic Research UK; Bryan Deane, ABPI; Rose Gallagher, Royal College of Nursing; Jon Harrison, BIVDA; Dr Roger Harrison, University of Manchester; Dr Kitty Healey, Defra; Professor Hilary Thomas, KPMG; Dr Michael Weinbren, Sherwood Forest NHS Foundation Trust and Adam Zerda, Becton Dickinson.
The agenda in summary
- Prevention and control of infections, and the public health benefits of tackling AMR;
- Collaboration, encouraging innovation, and financial incentives for protecting existing antimicrobials and advancing new development;
- Supporting the development and use of new vaccines, therapeutics, and diagnostics;
- Appropriate prescribing and reducing healthcare-associated infections - improving diagnostics, managing patient expectations, and engaging with clinicians, vets, and farmers; and
- Meeting the goals of the UK AMR strategy.
Policymakers attending
Westminster Health Forum conferences typically attract strong interest from policymakers. This seminar will be an opportunity for stakeholders to engage with officials who have reserved places representing DHSC; Defra; MHRA; the Office for Life Sciences; HM Treasury; BEIS; DIT; and DCMS.
